(+)-catechin multiple interactions ISO RGD:733265 6480464 [Catechin co-treated with Dietary Fats] affects the expression of CYBB mRNA CTD PMID:25861419 (+)-catechin multiple interactions ISO RGD:1350492 6480464 [Oxygen deficiency co-treated with Catechin] results in decreased expression of CYBB mRNA CTD PMID:35883890 (-)-epigallocatechin 3-gallate decreases expression EXP 6480464 epigallocatechin gallate results in decreased expression of CYBB mRNA, epigallocatechin gallate results in decreased expression of CYBB protein CTD PMID:27659729 (R)-carnitine multiple interactions EXP 6480464 Carnitine inhibits the reaction [Sunitinib results in increased expression of CYBB mRNA], Carnitine inhibits the reaction [Sunitinib results in increased expression of CYBB protein] CTD PMID:26581635 (R)-lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [Sodium Chloride, Dietary results in increased expression of CYBB] CTD PMID:26518973 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions ISO RGD:1350492 6480464 Quercetin inhibits the reaction [o, p'-DDT results in increased expression of CYBB mRNA] CTD PMID:35122929 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1350492 6480464 o, p'-DDT results in increased expression of CYBB mRNA CTD PMID:35122929 1,1-dichloroethene increases expression ISO RGD:733265 6480464 vinylidene chloride results in increased expression of CYBB mRNA CTD PMID:26682919 1-bromopropane increases expression EXP 6480464 1-bromopropane results in increased expression of CYBB mRNA, 1-bromopropane results in increased expression of CYBB protein CTD PMID:27452781 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CYBB mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CYBB mRNA CTD PMID:17351261 17beta-estradiol multiple interactions ISO RGD:1350492 6480464 Estradiol inhibits the reaction [AGT protein results in increased expression of CYBB mRNA], Estradiol inhibits the reaction [AGT protein results in increased expression of CYBB protein] CTD PMID:16097371 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYBB mRNA, [Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CYBB protein CTD PMID:21670166 , PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYBB mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1350492 6480464 2 more ... CTD PMID:20299304 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:733265 6480464 2 more ... CTD PMID:30294300 2,3',4,4',5-Pentachlorobiphenyl multiple interactions ISO RGD:1350492 6480464 2 more ... CTD PMID:20299304 , PMID:31251971 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1350492 6480464 2 more ... CTD PMID:31251971 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733265 6480464 Tetrachlorodibenzodioxin affects the expression of CYBB mRNA CTD PMID:26377647 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYBB mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYBB mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYBB mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733265 6480464 Tetrachlorodibenzodioxin results in increased expression of CYBB mRNA CTD PMID:28213091 2-butoxyethanol decreases expression ISO RGD:733265 6480464 n-butoxyethanol results in decreased expression of CYBB mRNA CTD PMID:19812364 2-tert-butylhydroquinone multiple interactions EXP 6480464 2-tert-butylhydroquinone inhibits the reaction [Sodium Chloride, Dietary results in increased expression of CYBB protein] CTD PMID:28844481 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1350492 6480464 3 more ... CTD PMID:20299304 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CYBB mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:733265 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CYBB mRNA CTD PMID:30951980 4-hydroxy-TEMPO decreases expression EXP 6480464 tempol results in decreased expression of CYBB, tempol results in decreased expression of CYBB mRNA CTD PMID:16685210 , PMID:20943769 4-hydroxynon-2-enal increases abundance ISO RGD:733265 6480464 CYBB protein results in increased abundance of 4-hydroxy-2-nonenal CTD PMID:19417757 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CYBB mRNA CTD PMID:23921912 , PMID:24780913 7-ketocholesterol affects localization ISO RGD:733265 6480464 7-ketocholesterol affects the localization of CYBB protein CTD PMID:28633109 7-ketocholesterol multiple interactions ISO RGD:733265 6480464 Amitriptyline inhibits the reaction [7-ketocholesterol affects the localization of CYBB protein], Amitriptyline inhibits the reaction [7-ketocholesterol analog affects the localization of CYBB protein] CTD PMID:28633109 acetaldehyde increases expression ISO RGD:1350492 6480464 Acetaldehyde results in increased expression of CYBB mRNA CTD PMID:18845238 acetamide increases expression EXP 6480464 acetamide results in increased expression of CYBB mRNA CTD PMID:31881176 acetylcholine multiple interactions ISO RGD:733265 6480464 CYBB gene mutant form inhibits the reaction [Nitroglycerin results in decreased susceptibility to Acetylcholine] CTD PMID:18522491 adenine multiple interactions EXP 6480464 camostat inhibits the reaction [Adenine results in increased expression of CYBB mRNA] CTD PMID:25766432 adenine increases expression EXP 6480464 Adenine results in increased expression of CYBB mRNA CTD PMID:25766432 aflatoxin B1 decreases methylation ISO RGD:1350492 6480464 Aflatoxin B1 results in decreased methylation of CYBB gene CTD PMID:27153756 agomelatine multiple interactions EXP 6480464 agomelatine inhibits the reaction [Galactose results in increased expression of CYBB protein] CTD PMID:34673010 AICA ribonucleotide multiple interactions EXP 6480464 AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of CYBB protein] CTD PMID:21195169 aldehydo-D-glucose multiple interactions ISO RGD:733265 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein more ... CTD PMID:21925195 aldehydo-D-glucose increases expression ISO RGD:1350492 6480464 Glucose results in increased expression of CYBB mRNA, Glucose results in increased expression of CYBB protein CTD PMID:31494106 , PMID:34464088 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of CYBB mRNA, Glucose results in increased expression of CYBB protein CTD PMID:26054749 , PMID:31838053 aldehydo-D-glucose multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]], Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein] CTD PMID:26054749 aldehydo-D-glucose increases localization EXP 6480464 Glucose results in increased localization of CYBB protein CTD PMID:22253932 aldehydo-D-glucose multiple interactions ISO RGD:1350492 6480464 acetovanillone inhibits the reaction [Glucose results in increased expression of and results in increased activity of CYBB protein] more ... CTD PMID:19878672 more ... all-trans-retinoic acid increases expression ISO RGD:1350492 6480464 Tretinoin results in increased expression of CYBB mRNA CTD PMID:15498508 more ... all-trans-retinoic acid multiple interactions ISO RGD:1350492 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of CYBB mRNA CTD PMID:15894607 allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYBB mRNA CTD PMID:33396045 alpha-D-galactose increases expression EXP 6480464 Galactose results in increased expression of CYBB protein CTD PMID:34673010 alpha-D-galactose multiple interactions EXP 6480464 agomelatine inhibits the reaction [Galactose results in increased expression of CYBB protein], Melatonin inhibits the reaction [Galactose results in increased expression of CYBB protein] CTD PMID:34673010 alpha-linolenic acid multiple interactions EXP 6480464 alpha-Linolenic Acid inhibits the reaction [[Cholesterol co-treated with Particulate Matter] results in increased expression of CYBB protein] CTD PMID:30672636 amitriptyline multiple interactions ISO RGD:733265 6480464 Amitriptyline inhibits the reaction [7-ketocholesterol affects the localization of CYBB protein], Amitriptyline inhibits the reaction [7-ketocholesterol analog affects the localization of CYBB protein] CTD PMID:28633109 amitrole multiple interactions EXP 6480464 Amitrole promotes the reaction [Sodium Chloride, Dietary results in increased expression of CYBB protein] CTD PMID:25891026 amlodipine multiple interactions EXP 6480464 Amlodipine promotes the reaction [candesartan results in decreased expression of CYBB] CTD PMID:21107329 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYBB mRNA CTD PMID:16483693 anagliptin multiple interactions ISO RGD:1350492 6480464 anagliptin inhibits the reaction [Hydrogen Peroxide results in increased expression of CYBB mRNA] CTD PMID:31586451 antirheumatic drug decreases expression ISO RGD:1350492 6480464 Antirheumatic Agents results in decreased expression of CYBB mRNA CTD PMID:24449571 apocynin multiple interactions ISO RGD:1350492 6480464 acetovanillone inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYBB mRNA], acetovanillone inhibits the reaction [Glucose results in increased expression of and results in increased activity of CYBB protein] CTD PMID:19878672 , PMID:30797899 apocynin multiple interactions EXP 6480464 acetovanillone inhibits the reaction [Hydrogen Peroxide results in increased expression of CYBB mRNA] more ... CTD PMID:23270704 , PMID:24080574 aripiprazole multiple interactions ISO RGD:1350492 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of CYBB mRNA CTD PMID:31476115 aristolochic acid A decreases expression ISO RGD:1350492 6480464 aristolochic acid I results in decreased expression of CYBB mRNA CTD PMID:33212167 arsane decreases expression ISO RGD:733265 6480464 Arsenic results in decreased expression of CYBB mRNA CTD PMID:19654921 arsane increases expression EXP 6480464 Arsenic results in increased expression of CYBB protein CTD PMID:24348802 arsane multiple interactions EXP 6480464 Grape Seed Extract inhibits the reaction [Arsenic results in increased expression of CYBB protein] CTD PMID:24348802 arsenic atom decreases expression ISO RGD:733265 6480464 Arsenic results in decreased expression of CYBB mRNA CTD PMID:19654921 arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of CYBB protein CTD PMID:24348802 arsenic atom multiple interactions EXP 6480464 Grape Seed Extract inhibits the reaction [Arsenic results in increased expression of CYBB protein] CTD PMID:24348802 arsenite(3-) multiple interactions EXP 6480464 Telmisartan inhibits the reaction [arsenite results in increased expression of CYBB mRNA] CTD PMID:34339004 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of CYBB mRNA CTD PMID:34339004 arsenous acid decreases expression ISO RGD:733265 6480464 Arsenic Trioxide results in decreased expression of CYBB mRNA CTD PMID:28454374 arsenous acid multiple interactions ISO RGD:1350492 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CYBB mRNA CTD PMID:15894607 arsenous acid decreases expression ISO RGD:1350492 6480464 Arsenic Trioxide results in decreased expression of CYBB mRNA CTD PMID:20458559 astaxanthin decreases expression EXP 6480464 astaxanthine results in decreased expression of CYBB mRNA CTD PMID:23272707 astaxanthin multiple interactions EXP 6480464 astaxanthine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CYBB mRNA] more ... CTD PMID:23272707 atrazine increases expression ISO RGD:733265 6480464 Atrazine results in increased expression of CYBB mRNA, Atrazine results in increased expression of CYBB protein CTD PMID:26256823 benzene multiple interactions ISO RGD:733265 6480464 [Deferoxamine co-treated with Benzene] results in increased expression of CYBB protein more ... CTD PMID:35661779 benzene increases expression ISO RGD:733265 6480464 Benzene results in increased expression of CYBB mRNA, Benzene results in increased expression of CYBB protein CTD PMID:35661779 benzo[a]pyrene decreases expression ISO RGD:733265 6480464 Benzo(a)pyrene results in decreased expression of CYBB mRNA CTD PMID:21569818 benzo[a]pyrene affects methylation ISO RGD:1350492 6480464 Benzo(a)pyrene affects the methylation of CYBB 3' UTR CTD PMID:27901495 Besigomsin multiple interactions ISO RGD:733265 6480464 schizandrol B inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CYBB protein] CTD PMID:24211520 bezafibrate increases expression ISO RGD:733265 6480464 Bezafibrate results in increased expression of CYBB protein CTD PMID:20594415 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYBB mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO RGD:733265 6480464 bisphenol A results in increased expression of CYBB mRNA CTD PMID:32156529 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Dietary Fats] results in increased expression of CYBB mRNA CTD PMID:25112833 bisphenol F increases expression ISO RGD:733265 6480464 bisphenol F results in increased expression of CYBB mRNA CTD PMID:30951980 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of CYBB mRNA CTD PMID:24136188 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of CYBB mRNA, Cadmium results in increased expression of CYBB protein CTD PMID:21787725 , PMID:23916567 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CYBB mRNA CTD PMID:33453195 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CYBB mRNA CTD PMID:25993096 cadmium dichloride multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CYBB protein] more ... CTD PMID:21195169 cadmium dichloride increases expression ISO RGD:1350492 6480464 Cadmium Chloride results in increased expression of CYBB protein CTD PMID:21195169 calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of CYBB mRNA, Calcitriol results in decreased expression of CYBB protein CTD PMID:32147540 calcium silicate increases expression ISO RGD:733265 6480464 calcium silicate results in increased expression of CYBB mRNA CTD PMID:29279043 camostat multiple interactions EXP 6480464 camostat inhibits the reaction [Adenine results in increased expression of CYBB mRNA] CTD PMID:25766432 candesartan multiple interactions EXP 6480464 Amlodipine promotes the reaction [candesartan results in decreased expression of CYBB], Hydrochlorothiazide promotes the reaction [candesartan results in decreased expression of CYBB] CTD PMID:21107329 candesartan decreases expression EXP 6480464 candesartan results in decreased expression of CYBB, candesartan results in decreased expression of CYBB mRNA CTD PMID:16685210 , PMID:21107329 cannabidiol multiple interactions ISO RGD:733265 6480464 Cannabidiol inhibits the reaction [Ethanol results in increased expression of CYBB mRNA] CTD PMID:28935932 capsaicin multiple interactions ISO RGD:733265 6480464 CYBB protein affects the reaction [TRPV1 protein results in increased susceptibility to Capsaicin] CTD PMID:18203709 capsaicin multiple interactions EXP 6480464 CYBB mutant form inhibits the reaction [Capsaicin results in increased expression of STAT1 protein] CTD PMID:20712533 captan decreases expression ISO RGD:733265 6480464 Captan results in decreased expression of CYBB mRNA CTD PMID:31558096 CGP-42112A multiple interactions ISO RGD:733265 6480464 CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of CYBB mRNA] more ... CTD PMID:25446015 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of CYBB mRNA CTD PMID:23125180 chlorpyrifos increases expression ISO RGD:733265 6480464 Chlorpyrifos results in increased expression of CYBB protein CTD PMID:32120800 cholesterol affects localization ISO RGD:733265 6480464 Cholesterol analog affects the localization of CYBB protein CTD PMID:28633109 cholesterol multiple interactions EXP 6480464 [Cholesterol co-treated with Particulate Matter] results in increased expression of CYBB protein more ... CTD PMID:26606054 , PMID:30672636 choline multiple interactions ISO RGD:733265 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of CYBB mRNA, PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in increased expression of CYBB mRNA] CTD PMID:29246445 chromium(6+) increases expression ISO RGD:1350492 6480464 chromium hexavalent ion results in increased expression of CYBB protein CTD PMID:21742780 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of CYBB mRNA CTD PMID:23603837 , PMID:25184746 cisplatin increases expression ISO RGD:1350492 6480464 Cisplatin results in increased expression of CYBB mRNA CTD PMID:27594783 cisplatin multiple interactions EXP 6480464 Eicosanoids analog inhibits the reaction [Cisplatin results in increased expression of CYBB mRNA], fisetin inhibits the reaction [Cisplatin results in increased expression of CYBB mRNA] CTD PMID:23603837 , PMID:25184746 cobalt atom decreases expression EXP 6480464 Cobalt results in decreased expression of CYBB mRNA CTD PMID:17967803 cocaine increases expression ISO RGD:733265 6480464 Cocaine results in increased expression of CYBB protein CTD PMID:18952886 cocaine increases response to substance ISO RGD:733265 6480464 CYBB results in increased susceptibility to Cocaine CTD PMID:18952886 corosolic acid multiple interactions ISO RGD:733265 6480464 corosolic acid inhibits the reaction [Doxorubicin results in increased expression of CYBB mRNA], corosolic acid inhibits the reaction [Doxorubicin results in increased expression of CYBB protein] CTD PMID:34296331 corosolic acid multiple interactions EXP 6480464 corosolic acid inhibits the reaction [Doxorubicin results in increased expression of CYBB protein], PRKAA2 protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in increased expression of CYBB protein]] CTD PMID:34296331 cyfluthrin increases expression ISO RGD:1350492 6480464 cyfluthrin results in increased expression of CYBB mRNA CTD PMID:31330490 cyfluthrin multiple interactions ISO RGD:1350492 6480464 Melatonin inhibits the reaction [cyfluthrin results in increased expression of CYBB mRNA] CTD PMID:31330490 cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYBB mRNA CTD PMID:33396045 cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYBB mRNA CTD PMID:33396045 D-glucose multiple interactions ISO RGD:733265 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein more ... CTD PMID:21925195 D-glucose increases expression ISO RGD:1350492 6480464 Glucose results in increased expression of CYBB mRNA, Glucose results in increased expression of CYBB protein CTD PMID:31494106 , PMID:34464088 D-glucose multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]], Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein] CTD PMID:26054749 D-glucose increases expression EXP 6480464 Glucose results in increased expression of CYBB mRNA, Glucose results in increased expression of CYBB protein CTD PMID:26054749 , PMID:31838053 D-glucose multiple interactions ISO RGD:1350492 6480464 acetovanillone inhibits the reaction [Glucose results in increased expression of and results in increased activity of CYBB protein] more ... CTD PMID:19878672 more ... D-glucose increases localization EXP 6480464 Glucose results in increased localization of CYBB protein CTD PMID:22253932 daunorubicin increases expression EXP 6480464 Daunorubicin results in increased expression of CYBB mRNA CTD PMID:27090888 Deoxycorticosterone acetate multiple interactions ISO RGD:733265 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CYBB mRNA more ... CTD PMID:21368743 , PMID:27678262 desferrioxamine B multiple interactions ISO RGD:733265 6480464 [Deferoxamine co-treated with Benzene] results in increased expression of CYBB protein, Deferoxamine inhibits the reaction [Benzene results in increased expression of CYBB mRNA] CTD PMID:35661779 dexamethasone multiple interactions ISO RGD:1350492 6480464 Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CYBB mRNA] CTD PMID:9794432 dexamethasone multiple interactions ISO RGD:733265 6480464 Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CYBB mRNA] CTD PMID:27568862 dextran sulfate increases expression ISO RGD:733265 6480464 Dextran Sulfate results in increased expression of CYBB mRNA, Dextran Sulfate results in increased expression of CYBB protein CTD PMID:20637373 , PMID:23894361 diallyl trisulfide multiple interactions EXP 6480464 diallyl trisulfide inhibits the reaction [Doxorubicin results in increased expression of CYBB protein] CTD PMID:29087013 diarsenic trioxide decreases expression ISO RGD:733265 6480464 Arsenic Trioxide results in decreased expression of CYBB mRNA CTD PMID:28454374 diarsenic trioxide multiple interactions ISO RGD:1350492 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CYBB mRNA CTD PMID:15894607 diarsenic trioxide decreases expression ISO RGD:1350492 6480464 Arsenic Trioxide results in decreased expression of CYBB mRNA CTD PMID:20458559 dibenziodolium multiple interactions ISO RGD:1350492 6480464 diphenyleneiodonium inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYBB mRNA], diphenyleneiodonium inhibits the reaction [S100B protein results in increased expression of CYBB mRNA] CTD PMID:17327432 , PMID:30797899 dibenziodolium multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CYBB mRNA], diphenyleneiodonium inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CYBB protein] CTD PMID:23272707 dibenziodolium multiple interactions ISO RGD:733265 6480464 diphenyleneiodonium inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CYBB protein], diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of CYBB protein] CTD PMID:29183754 dibromine increases expression EXP 6480464 Bromine results in increased expression of CYBB protein CTD PMID:32979061 dibutylstannane increases expression ISO RGD:733265 6480464 di-n-butyltin results in increased expression of CYBB mRNA CTD PMID:24631921 dichlorvos increases expression EXP 6480464 Dichlorvos results in increased expression of CYBB mRNA, Dichlorvos results in increased expression of CYBB protein CTD PMID:21964614 diclofenac increases expression ISO RGD:733265 6480464 Diclofenac results in increased expression of CYBB mRNA CTD PMID:26934552 dimethylarsinic acid multiple interactions ISO RGD:733265 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYBB mRNA CTD PMID:34876320 diminazene diaceturate decreases expression ISO RGD:1350492 6480464 diminazene aceturate results in decreased expression of CYBB protein CTD PMID:29977014 dioxygen multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CYBB mRNA], Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CYBB protein] CTD PMID:24492474 dioxygen multiple interactions ISO RGD:1350492 6480464 [Oxygen deficiency co-treated with Catechin] results in decreased expression of CYBB mRNA CTD PMID:35883890 dioxygen increases expression ISO RGD:1350492 6480464 Oxygen deficiency results in increased expression of CYBB mRNA CTD PMID:35883890 dioxygen multiple interactions ISO RGD:733265 6480464 [CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of CYBB mRNA more ... CTD PMID:21925195 , PMID:24835767 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of CYBB mRNA, Oxygen deficiency results in increased expression of CYBB protein CTD PMID:24492474 dorsomorphin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]] CTD PMID:26054749 doxorubicin multiple interactions ISO RGD:733265 6480464 corosolic acid inhibits the reaction [Doxorubicin results in increased expression of CYBB mRNA] more ... CTD PMID:17275678 , PMID:34296331 doxorubicin multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of CYBB protein] more ... CTD PMID:29087013 more ... doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of CYBB mRNA, Doxorubicin results in increased expression of CYBB protein CTD PMID:29087013 more ... doxorubicin increases expression ISO RGD:733265 6480464 Doxorubicin results in increased expression of CYBB mRNA, Doxorubicin results in increased expression of CYBB protein CTD PMID:31158416 , PMID:34296331 eckol decreases expression ISO RGD:1350492 6480464 eckol results in decreased expression of CYBB protein CTD PMID:21514314 edaravone multiple interactions EXP 6480464 Edaravone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CYBB mRNA] CTD PMID:18643790 endosulfan increases expression ISO RGD:733265 6480464 Endosulfan results in increased expression of CYBB mRNA CTD PMID:25199686 ethanol increases expression ISO RGD:1350492 6480464 Ethanol results in increased expression of CYBB mRNA, Ethanol results in increased expression of CYBB protein CTD PMID:18845238 , PMID:26079697 ethanol increases expression ISO RGD:733265 6480464 Ethanol results in increased expression of CYBB mRNA, Ethanol results in increased expression of CYBB protein CTD PMID:23978445 more ... ethanol multiple interactions ISO RGD:733265 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Ethanol results in increased expression of CYBB mRNA] more ... CTD PMID:23978445 more ... ethanol multiple interactions EXP 6480464 ginkgolide B inhibits the reaction [Ethanol results in increased expression of CYBB protein] CTD PMID:21704112 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYBB protein CTD PMID:21704112 fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYBB mRNA CTD PMID:33396045 ferrostatin-1 multiple interactions ISO RGD:733265 6480464 [ferrostatin-1 co-treated with Benzene] results in increased expression of CYBB protein, ferrostatin-1 inhibits the reaction [Benzene results in increased expression of CYBB mRNA] CTD PMID:35661779 filipin III multiple interactions ISO RGD:733265 6480464 Filipin inhibits the reaction [Homocysteine affects the localization of CYBB protein] CTD PMID:20036696 fisetin multiple interactions EXP 6480464 fisetin inhibits the reaction [Cisplatin results in increased expression of CYBB mRNA] CTD PMID:25184746 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of CYBB mRNA CTD PMID:18035473 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CYBB mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:733265 6480464 CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 mRNA] more ... CTD PMID:20116427 more ... folic acid affects response to substance ISO RGD:733265 6480464 CYBB protein affects the susceptibility to Folic Acid deficiency CTD PMID:20116427 folic acid increases response to substance ISO RGD:733265 6480464 CYBB results in increased susceptibility to Folic Acid CTD PMID:21647593 fructose multiple interactions EXP 6480464 [Dietary Fats co-treated with Fructose] results in increased expression of CYBB mRNA CTD PMID:19632207 galactose multiple interactions EXP 6480464 agomelatine inhibits the reaction [Galactose results in increased expression of CYBB protein], Melatonin inhibits the reaction [Galactose results in increased expression of CYBB protein] CTD PMID:34673010 galactose increases expression EXP 6480464 Galactose results in increased expression of CYBB protein CTD PMID:34673010 genistein decreases expression ISO RGD:733265 6480464 Genistein results in decreased expression of CYBB mRNA CTD PMID:24967385 genistein multiple interactions ISO RGD:733265 6480464 Genistein inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CYBB protein] CTD PMID:29183754 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CYBB mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CYBB mRNA CTD PMID:33387578 geraniol multiple interactions ISO RGD:1350492 6480464 geraniol inhibits the reaction [Palmitic Acid results in increased expression of CYBB protein] CTD PMID:27107694 geraniol multiple interactions ISO RGD:733265 6480464 geraniol inhibits the reaction [Dietary Fats results in increased expression of CYBB protein] CTD PMID:27107694 ginkgolide B multiple interactions EXP 6480464 ginkgolide B inhibits the reaction [Ethanol results in increased expression of CYBB protein] CTD PMID:21704112 glucose multiple interactions ISO RGD:733265 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein more ... CTD PMID:21925195 glucose increases expression ISO RGD:1350492 6480464 Glucose results in increased expression of CYBB mRNA, Glucose results in increased expression of CYBB protein CTD PMID:31494106 , PMID:34464088 glucose increases expression EXP 6480464 Glucose results in increased expression of CYBB mRNA, Glucose results in increased expression of CYBB protein CTD PMID:26054749 , PMID:31838053 glucose multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]], Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein] CTD PMID:26054749 glucose multiple interactions ISO RGD:1350492 6480464 acetovanillone inhibits the reaction [Glucose results in increased expression of and results in increased activity of CYBB protein] more ... CTD PMID:19878672 more ... glucose increases localization EXP 6480464 Glucose results in increased localization of CYBB protein CTD PMID:22253932 glyburide multiple interactions ISO RGD:733265 6480464 Glyburide inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of CYBB protein], Glyburide inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYBB protein] CTD PMID:32375810 , PMID:34052309 GW 501516 multiple interactions ISO RGD:1350492 6480464 GW 501516 inhibits the reaction [APP gene mutant form results in increased expression of CYBB protein] CTD PMID:22886847 hemin multiple interactions EXP 6480464 Hemin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CYBB mRNA] more ... CTD PMID:23272707 hexadecanoic acid increases expression EXP 6480464 Palmitic Acid results in increased expression of CYBB mRNA CTD PMID:24080574 hexadecanoic acid multiple interactions ISO RGD:1350492 6480464 geraniol inhibits the reaction [Palmitic Acid results in increased expression of CYBB protein] CTD PMID:27107694 hexadecanoic acid increases expression ISO RGD:1350492 6480464 Palmitic Acid results in increased expression of CYBB protein CTD PMID:27107694 hexadecanoic acid multiple interactions EXP 6480464 acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of CYBB mRNA], U 0126 inhibits the reaction [Palmitic Acid results in increased expression of CYBB mRNA] CTD PMID:24080574 homocysteine multiple interactions ISO RGD:733265 6480464 CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 mRNA] more ... CTD PMID:20036696 more ... homocysteine increases expression ISO RGD:733265 6480464 Homocysteine results in increased expression of CYBB mRNA, Homocysteine results in increased expression of CYBB protein CTD PMID:20116427 homocysteine affects localization ISO RGD:733265 6480464 Homocysteine affects the localization of CYBB protein CTD PMID:20036696 hydrochlorothiazide multiple interactions EXP 6480464 Hydrochlorothiazide promotes the reaction [candesartan results in decreased expression of CYBB] CTD PMID:21107329 hydrogen peroxide increases expression ISO RGD:1350492 6480464 Hydrogen Peroxide results in increased expression of CYBB mRNA, Hydrogen Peroxide results in increased expression of CYBB protein CTD PMID:19401454 , PMID:31586451 hydrogen peroxide multiple interactions ISO RGD:1350492 6480464 anagliptin inhibits the reaction [Hydrogen Peroxide results in increased expression of CYBB mRNA] CTD PMID:31586451 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of CYBB mRNA, Hydrogen Peroxide results in increased expression of CYBB protein CTD PMID:23270704 hydrogen peroxide multiple interactions EXP 6480464 4-chlorobenzyltetrahydroberberine inhibits the reaction [Hydrogen Peroxide results in increased expression of CYBB mRNA] more ... CTD PMID:23270704 hydroxylamine multiple interactions EXP 6480464 Hydroxylamine promotes the reaction [Sodium Chloride, Dietary results in increased expression of CYBB protein] CTD PMID:28185984 icosanoid multiple interactions EXP 6480464 Eicosanoids analog inhibits the reaction [Cisplatin results in increased expression of CYBB mRNA] CTD PMID:23603837 iron dextran increases expression EXP 6480464 Iron-Dextran Complex results in increased expression of CYBB protein CTD PMID:28700905 , PMID:29990562 ketamine increases expression ISO RGD:733265 6480464 Ketamine results in increased expression of CYBB CTD PMID:18063801 L-ascorbic acid increases expression ISO RGD:733265 6480464 Ascorbic Acid results in increased expression of CYBB protein CTD PMID:21570463 L-methionine multiple interactions ISO RGD:733265 6480464 Methionine inhibits the reaction [Acetaminophen results in increased expression of CYBB mRNA] CTD PMID:19739265 lead diacetate affects expression ISO RGD:733265 6480464 lead acetate affects the expression of CYBB mRNA CTD PMID:21829687 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of CYBB mRNA CTD PMID:22641619 lead diacetate increases expression ISO RGD:1350492 6480464 lead acetate results in increased expression of CYBB protein CTD PMID:15569323 lead(0) increases expression EXP 6480464 Lead results in increased expression of CYBB protein CTD PMID:25596430 lead(2+) increases expression EXP 6480464 Lead results in increased expression of CYBB protein CTD PMID:25596430 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of CYBB mRNA CTD PMID:35283115 lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [Sodium Chloride, Dietary results in increased expression of CYBB] CTD PMID:26518973 lipopolysaccharide multiple interactions ISO RGD:733265 6480464 CAV1 gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of CYBB mRNA] more ... CTD PMID:15795323 more ... lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CYBB protein CTD PMID:17448908 lipopolysaccharide increases activity ISO RGD:733265 6480464 Lipopolysaccharides results in increased activity of CYBB protein CTD PMID:19005069 lipopolysaccharide increases expression ISO RGD:733265 6480464 Lipopolysaccharides results in increased expression of CYBB mRNA, Lipopolysaccharides results in increased expression of CYBB protein CTD PMID:15795323 more ... lipopolysaccharide multiple interactions ISO RGD:1350492 6480464 CAV1 mutant form promotes the reaction [Lipopolysaccharides results in increased expression of CYBB mRNA] more ... CTD PMID:17855475 more ... lipopolysaccharide increases expression ISO RGD:1350492 6480464 Lipopolysaccharides results in increased expression of CYBB mRNA, Lipopolysaccharides results in increased expression of CYBB protein CTD PMID:17855475 , PMID:24835767 malathion multiple interactions ISO RGD:733265 6480464 Plant Extracts inhibits the reaction [Malathion results in increased expression of CYBB protein], Polyphenols inhibits the reaction [Malathion results in increased expression of CYBB protein] CTD PMID:32120800 malathion increases expression ISO RGD:733265 6480464 Malathion results in increased expression of CYBB protein CTD PMID:32120800 malonaldehyde increases abundance ISO RGD:733265 6480464 CYBB protein results in increased abundance of Malondialdehyde CTD PMID:19417757 maneb multiple interactions ISO RGD:1350492 6480464 [Paraquat co-treated with Maneb] results in increased expression of CYBB mRNA more ... CTD PMID:30797899 maneb multiple interactions ISO RGD:733265 6480464 [Maneb co-treated with Paraquat] results in increased expression of CYBB protein more ... CTD PMID:29568078 more ... manumycin A multiple interactions ISO RGD:733265 6480464 manumycin inhibits the reaction [Acetaminophen results in increased expression of CYBB mRNA] CTD PMID:19739265 medroxyprogesterone acetate multiple interactions EXP 6480464 [Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CYBB protein CTD PMID:21670166 melatonin multiple interactions ISO RGD:1350492 6480464 Melatonin inhibits the reaction [cyfluthrin results in increased expression of CYBB mRNA] CTD PMID:31330490 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Galactose results in increased expression of CYBB protein] CTD PMID:34673010 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of CYBB protein] CTD PMID:35085591 methamphetamine multiple interactions EXP 6480464 CCK protein modified form inhibits the reaction [Methamphetamine promotes the reaction [NCF1 protein binds to CYBB protein]], Methamphetamine promotes the reaction [NCF1 protein binds to CYBB protein] CTD PMID:27565679 methyl beta-cyclodextrin multiple interactions ISO RGD:733265 6480464 methyl-beta-cyclodextrin inhibits the reaction [Homocysteine affects the localization of CYBB protein] CTD PMID:20036696 methylarsonic acid multiple interactions ISO RGD:733265 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYBB mRNA CTD PMID:34876320 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of CYBB mRNA CTD PMID:31378766 microcystin-LR increases expression ISO RGD:733265 6480464 cyanoginosin LR results in increased expression of CYBB mRNA CTD PMID:17654400 monocrotaline increases expression EXP 6480464 Monocrotaline results in increased expression of CYBB mRNA, Monocrotaline results in increased expression of CYBB protein CTD PMID:24835767 , PMID:24947524 morphine increases expression ISO RGD:733265 6480464 Morphine results in increased expression of CYBB protein CTD PMID:14871405 morphine multiple interactions ISO RGD:733265 6480464 Saquinavir inhibits the reaction [Morphine results in increased expression of CYBB protein] CTD PMID:14871405 N(gamma)-nitro-L-arginine methyl ester multiple interactions EXP 6480464 Sildenafil Citrate inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of CYBB protein], tangeretin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of CYBB protein] CTD PMID:32479886 N(gamma)-nitro-L-arginine methyl ester increases expression EXP 6480464 NG-Nitroarginine Methyl Ester results in increased expression of CYBB protein CTD PMID:32479886 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CYBB protein], Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of CYBB protein] CTD PMID:21195169 , PMID:29087013 N-formyl-L-methionyl-L-leucyl-L-phenylalanine increases activity ISO RGD:733265 6480464 N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CYBB protein CTD PMID:29183754 N-formyl-L-methionyl-L-leucyl-L-phenylalanine multiple interactions ISO RGD:733265 6480464 diphenyleneiodonium inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CYBB protein], Genistein inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CYBB protein] CTD PMID:29183754 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CYBB mRNA, 1-Methyl-4-phenylpyridinium results in increased expression of CYBB protein CTD PMID:18643790 , PMID:23272707 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:733265 6480464 1-Methyl-4-phenylpyridinium promotes the reaction [[lipopolysaccharide, E. coli O26-B6 co-treated with IFNG protein] results in increased expression of CYBB mRNA] CTD PMID:30686998 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1350492 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of CYBB protein CTD PMID:28851138 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1350492 6480464 rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of CYBB protein] more ... CTD PMID:28851138 , PMID:30513525 N-methyl-4-phenylpyridinium increases expression ISO RGD:1350492 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CYBB protein CTD PMID:30513525 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 astaxanthine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CYBB mRNA] more ... CTD PMID:18643790 , PMID:23272707 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of CYBB mRNA CTD PMID:25380136 NADP zwitterion multiple interactions ISO RGD:733265 6480464 CYBB protein promotes the reaction [[Doxorubicin co-treated with NADP] results in increased abundance of Superoxides] CTD PMID:17275678 NADP(+) multiple interactions ISO RGD:733265 6480464 CYBB protein promotes the reaction [[Doxorubicin co-treated with NADP] results in increased abundance of Superoxides] CTD PMID:17275678 nebivolol multiple interactions EXP 6480464 Nebivolol inhibits the reaction [AGT protein results in increased expression of CYBB mRNA] CTD PMID:16940222 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of CYBB mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:1350492 6480464 Nickel results in increased expression of CYBB mRNA CTD PMID:24768652 , PMID:25583101 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of CYBB mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of CYBB mRNA CTD PMID:26534761 nitroglycerin multiple interactions ISO RGD:733265 6480464 CYBB gene mutant form inhibits the reaction [Nitroglycerin results in decreased susceptibility to Acetylcholine], Rosuvastatin Calcium inhibits the reaction [Nitroglycerin results in increased expression of CYBB mRNA] CTD PMID:16633368 , PMID:18522491 nitroglycerin decreases expression EXP 6480464 Nitroglycerin results in decreased expression of CYBB mRNA CTD PMID:17493633 nitroglycerin increases expression ISO RGD:733265 6480464 Nitroglycerin results in increased expression of CYBB mRNA CTD PMID:16633368 nitroglycerin decreases response to substance ISO RGD:733265 6480464 CYBB gene mutant form results in decreased susceptibility to Nitroglycerin CTD PMID:18522491 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of CYBB mRNA CTD PMID:23358140 oxidopamine multiple interactions ISO RGD:1350492 6480464 N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Oxidopamine results in increased expression of CYBB protein] CTD PMID:17855475 oxidopamine increases expression ISO RGD:1350492 6480464 Oxidopamine results in increased expression of CYBB protein CTD PMID:17855475 ozone increases expression ISO RGD:1350492 6480464 Ozone results in increased expression of CYBB mRNA CTD PMID:31476115 ozone multiple interactions ISO RGD:733265 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CYBB mRNA more ... CTD PMID:34911549 ozone multiple interactions ISO RGD:1350492 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of CYBB mRNA CTD PMID:31476115 palytoxin increases expression ISO RGD:1350492 6480464 palytoxin results in increased expression of CYBB mRNA CTD PMID:23142474 paracetamol multiple interactions ISO RGD:733265 6480464 manumycin inhibits the reaction [Acetaminophen results in increased expression of CYBB mRNA] more ... CTD PMID:19739265 , PMID:27866976 paracetamol increases expression ISO RGD:733265 6480464 Acetaminophen results in increased expression of CYBB mRNA, Acetaminophen results in increased expression of CYBB protein CTD PMID:19739265 more ... paraquat multiple interactions ISO RGD:1350492 6480464 [Paraquat co-treated with Maneb] results in increased expression of CYBB mRNA more ... CTD PMID:30797899 paraquat increases expression ISO RGD:1350492 6480464 Paraquat results in increased expression of CYBB mRNA CTD PMID:34097952 paraquat multiple interactions ISO RGD:733265 6480464 [Maneb co-treated with Paraquat] results in increased expression of CYBB protein more ... CTD PMID:29568078 more ... patulin increases expression ISO RGD:1350492 6480464 Patulin results in increased expression of CYBB mRNA, Patulin results in increased expression of CYBB protein CTD PMID:33577942 PD123319 multiple interactions ISO RGD:733265 6480464 PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of CYBB mRNA]], PD 123319 inhibits the reaction [CGP 42112A inhibits the reaction [[AGT protein co-treated with Rotenone] results in increased expression of CYBB protein]] CTD PMID:25446015 phenobarbital affects expression ISO RGD:733265 6480464 Phenobarbital affects the expression of CYBB mRNA CTD PMID:23091169 phenol increases expression EXP 6480464 Phenol results in increased expression of CYBB mRNA CTD PMID:16785328 phorbol 13-acetate 12-myristate increases activity ISO RGD:733265 6480464 Tetradecanoylphorbol Acetate results in increased activity of CYBB protein CTD PMID:29183754 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:733265 6480464 diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of CYBB protein], Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of CYBB protein] CTD PMID:29183754 phorbol 13-acetate 12-myristate increases expression ISO RGD:1350492 6480464 Tetradecanoylphorbol Acetate results in increased expression of CYBB mRNA CTD PMID:9794432 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1350492 6480464 Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CYBB mRNA] CTD PMID:9794432 pirinixic acid multiple interactions ISO RGD:733265 6480464 pirinixic acid inhibits the reaction [PNPLA2 gene mutant form results in increased expression of CYBB mRNA] CTD PMID:25285770 prodigiosin multiple interactions ISO RGD:733265 6480464 Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein] CTD PMID:21925195 quercetin multiple interactions EXP 6480464 Quercetin analog inhibits the reaction [AGT protein results in increased expression of CYBB mRNA] CTD PMID:19794523 quercetin multiple interactions ISO RGD:1350492 6480464 Quercetin inhibits the reaction [o, p'-DDT results in increased expression of CYBB mRNA] CTD PMID:35122929 ramipril decreases expression ISO RGD:733265 6480464 Ramipril results in decreased expression of CYBB mRNA CTD PMID:16891913 reactive oxygen species multiple interactions EXP 6480464 [[[Rosuvastatin Calcium results in decreased expression of CYBB] co-treated with [Rosuvastatin Calcium results in decreased expression of CYBA]] co-treated with [Rosuvastatin Calcium results in increased expression of SOD1]] results in decreased abundance of Reactive Oxygen Species CTD PMID:21562509 reactive oxygen species multiple interactions ISO RGD:733265 6480464 CYBB mutant form inhibits the reaction [Ethanol results in increased abundance of Reactive Oxygen Species] CTD PMID:23978445 resveratrol multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]] more ... CTD PMID:23593274 more ... resveratrol multiple interactions ISO RGD:1350492 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of CYBB mRNA CTD PMID:23557933 resveratrol multiple interactions ISO RGD:733265 6480464 Resveratrol inhibits the reaction [Titanium results in increased expression of CYBB mRNA] CTD PMID:26878849 resveratrol decreases expression EXP 6480464 Resveratrol results in decreased expression of CYBB mRNA CTD PMID:20081535 , PMID:24322615 resveratrol increases expression ISO RGD:733265 6480464 Resveratrol results in increased expression of CYBB mRNA CTD PMID:20610621 resveratrol decreases expression ISO RGD:733265 6480464 Resveratrol results in decreased expression of CYBB mRNA, Resveratrol results in decreased expression of CYBB protein CTD PMID:19478208 more ... rosuvastatin calcium multiple interactions ISO RGD:733265 6480464 Rosuvastatin Calcium inhibits the reaction [Nitroglycerin results in increased expression of CYBB mRNA] CTD PMID:16633368 rosuvastatin calcium multiple interactions EXP 6480464 [[[Rosuvastatin Calcium results in decreased expression of CYBB] co-treated with [Rosuvastatin Calcium results in decreased expression of CYBA]] co-treated with [Rosuvastatin Calcium results in increased expression of SOD1]] results in decreased abundance of Reactive Oxygen Species CTD PMID:21562509 rosuvastatin calcium decreases expression EXP 6480464 Rosuvastatin Calcium results in decreased expression of CYBB CTD PMID:21562509 rotenone multiple interactions ISO RGD:733265 6480464 7-Ala-angiotensin (1-7) inhibits the reaction [angiotensin I (1-7) inhibits the reaction [Rotenone results in increased expression of CYBB mRNA]] more ... CTD PMID:25446015 more ... rotenone increases expression EXP 6480464 Rotenone results in increased expression of CYBB protein CTD PMID:23593274 rotenone multiple interactions EXP 6480464 resveratrol inhibits the reaction [Rotenone results in increased expression of CYBB protein] CTD PMID:23593274 rotenone increases expression ISO RGD:733265 6480464 Rotenone results in increased expression of CYBB mRNA, Rotenone results in increased expression of CYBB protein CTD PMID:25446015 , PMID:29665408 Salidroside multiple interactions ISO RGD:1350492 6480464 rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of CYBB protein], sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of CYBB protein]] CTD PMID:28851138 Salvianolic acid A multiple interactions EXP 6480464 salvianolic acid A inhibits the reaction [Thioacetamide results in increased expression of CYBB protein] CTD PMID:19822164 salvianolic acid B multiple interactions EXP 6480464 salvianolic acid B inhibits the reaction [PDGFB protein results in increased expression of CYBB protein], salvianolic acid B inhibits the reaction [Thioacetamide results in increased expression of CYBB protein] CTD PMID:19822164 saquinavir multiple interactions ISO RGD:733265 6480464 Saquinavir inhibits the reaction [Morphine results in increased expression of CYBB protein] CTD PMID:14871405 SB 203580 multiple interactions ISO RGD:733265 6480464 SB 203580 inhibits the reaction [Ethanol results in increased expression of CYBB mRNA] CTD PMID:23978445 sildenafil citrate multiple interactions EXP 6480464 Sildenafil Citrate inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of CYBB protein] CTD PMID:32479886 silibinin multiple interactions EXP 6480464 Silybin inhibits the reaction [sodium arsenite results in increased expression of CYBB] CTD PMID:24062023 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CYBB mRNA CTD PMID:32721576 simvastatin multiple interactions ISO RGD:1350492 6480464 Simvastatin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CYBB protein] CTD PMID:30513525 sirolimus multiple interactions EXP 6480464 Sirolimus inhibits the reaction [Cadmium Chloride results in increased expression of CYBB protein] CTD PMID:21195169 sirtinol multiple interactions ISO RGD:1350492 6480464 sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of CYBB protein]] CTD PMID:28851138 sodium arsenate multiple interactions ISO RGD:733265 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYBB mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO RGD:1350492 6480464 sodium arsenite results in decreased expression of CYBB mRNA CTD PMID:27908234 sodium arsenite multiple interactions ISO RGD:733265 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYBB mRNA CTD PMID:34876320 sodium arsenite multiple interactions ISO RGD:1350492 6480464 SFPQ protein affects the reaction [sodium arsenite results in increased expression of CYBB mRNA] CTD PMID:32066060 sodium arsenite increases expression ISO RGD:1350492 6480464 sodium arsenite results in increased expression of CYBB mRNA CTD PMID:32066060 sodium arsenite increases expression ISO RGD:733265 6480464 sodium arsenite results in increased expression of CYBB mRNA, sodium arsenite results in increased expression of CYBB protein CTD PMID:29044176 , PMID:33145626 sodium arsenite multiple interactions EXP 6480464 Grape Seed Extract inhibits the reaction [sodium arsenite results in increased expression of CYBB protein], Silybin inhibits the reaction [sodium arsenite results in increased expression of CYBB] CTD PMID:21605584 , PMID:24062023 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CYBB more ... CTD PMID:21605584 more ... sodium chloride multiple interactions ISO RGD:733265 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CYBB mRNA, CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CYBB mRNA] CTD PMID:27678262 sodium cholate multiple interactions EXP 6480464 [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of CYBB mRNA CTD PMID:26606054 spironolactone decreases expression EXP 6480464 Spironolactone results in decreased expression of CYBB protein CTD PMID:19114643 staurosporine multiple interactions ISO RGD:733265 6480464 Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of CYBB protein] CTD PMID:29183754 streptozocin increases expression ISO RGD:733265 6480464 Streptozocin results in increased expression of CYBB mRNA, Streptozocin results in increased expression of CYBB protein CTD PMID:21381899 , PMID:29420703 streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of CYBB protein, Metformin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of CYBB protein] CTD PMID:35085591 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of CYBB protein CTD PMID:19957251 streptozocin multiple interactions ISO RGD:733265 6480464 [fatostatin co-treated with Streptozocin] results in increased expression of CYBB mRNA, Telmisartan inhibits the reaction [Streptozocin results in increased expression of CYBB protein] CTD PMID:21381899 , PMID:29420703 succimer multiple interactions ISO RGD:1350492 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYBB mRNA CTD PMID:26378955 sulforaphane increases expression ISO RGD:1350492 6480464 sulforaphane results in increased expression of CYBB mRNA CTD PMID:26833863 sunitinib multiple interactions EXP 6480464 Carnitine inhibits the reaction [Sunitinib results in increased expression of CYBB mRNA] more ... CTD PMID:26581635 sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of CYBB mRNA, Sunitinib results in increased expression of CYBB protein CTD PMID:26581635 superoxide multiple interactions ISO RGD:733265 6480464 CYBB mutant form inhibits the reaction [Homocysteine results in increased abundance of Superoxides] more ... CTD PMID:17275678 more ... superoxide multiple interactions ISO RGD:1350492 6480464 IL1B protein promotes the reaction [CYBB protein results in increased chemical synthesis of Superoxides] CTD PMID:16354686 tamibarotene increases expression ISO RGD:1350492 6480464 tamibarotene results in increased expression of CYBB mRNA CTD PMID:15498508 tangeretin multiple interactions EXP 6480464 tangeretin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of CYBB protein] CTD PMID:32479886 taurine multiple interactions ISO RGD:733265 6480464 Taurine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYBB protein] CTD PMID:29568078 telmisartan multiple interactions ISO RGD:733265 6480464 telmisartan inhibits the reaction [Streptozocin results in increased expression of CYBB protein] CTD PMID:21381899 telmisartan multiple interactions EXP 6480464 Telmisartan inhibits the reaction [arsenite results in increased expression of CYBB mRNA] CTD PMID:34339004 telmisartan multiple interactions ISO RGD:1350492 6480464 Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB mRNA], Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB protein] CTD PMID:34464088 telmisartan decreases expression EXP 6480464 telmisartan results in decreased expression of CYBB mRNA CTD PMID:19171132 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYBB mRNA CTD PMID:32741896 tetrachloromethane multiple interactions ISO RGD:733265 6480464 CYBB gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of COL1A2 mRNA], CYBB gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA] CTD PMID:17105591 tetrachloromethane increases expression ISO RGD:733265 6480464 Carbon Tetrachloride results in increased expression of CYBB mRNA CTD PMID:27339419 more ... tetrachloromethane decreases response to substance ISO RGD:733265 6480464 CYBB gene mutant form results in decreased susceptibility to Carbon Tetrachloride CTD PMID:17105591 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYBB protein CTD PMID:17854599 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CYBB mRNA CTD PMID:17854599 , PMID:30723492 tetrodotoxin multiple interactions ISO RGD:733265 6480464 [Tetrodotoxin co-treated with cariporide] inhibits the reaction [lipopolysaccharide more ... CTD PMID:24070585 thiacloprid increases expression ISO RGD:1350492 6480464 thiacloprid results in increased expression of CYBB mRNA CTD PMID:32201337 thioacetamide multiple interactions EXP 6480464 S100B protein promotes the reaction [Thioacetamide results in increased expression of CYBB protein] more ... CTD PMID:19822164 , PMID:34792689 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CYBB mRNA, Thioacetamide results in increased expression of CYBB protein CTD PMID:19822164 more ... titanium atom multiple interactions ISO RGD:733265 6480464 Resveratrol inhibits the reaction [Titanium results in increased expression of CYBB mRNA] CTD PMID:26878849 titanium atom increases expression ISO RGD:733265 6480464 Titanium results in increased expression of CYBB mRNA CTD PMID:26878849 titanium dioxide decreases expression ISO RGD:733265 6480464 titanium dioxide results in decreased expression of CYBB mRNA CTD PMID:27760801 , PMID:29264374 torcetrapib increases expression ISO RGD:1350492 6480464 torcetrapib results in increased expression of CYBB protein CTD PMID:25617244 trans-piceid multiple interactions EXP 6480464 polydatin inhibits the reaction [AGT protein modified form results in increased expression of CYBB mRNA], polydatin inhibits the reaction [AGT protein modified form results in increased expression of CYBB protein] CTD PMID:25488910 tremolite asbestos increases expression ISO RGD:733265 6480464 tremolite results in increased expression of CYBB mRNA CTD PMID:29279043 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of CYBB protein CTD PMID:26873547 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CYBB mRNA CTD PMID:33387578 triclosan decreases expression ISO RGD:1350492 6480464 Triclosan results in decreased expression of CYBB mRNA CTD PMID:30510588 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of CYBB mRNA CTD PMID:30589522 tungsten decreases expression ISO RGD:733265 6480464 Tungsten results in decreased expression of CYBB mRNA CTD PMID:30912803 valsartan multiple interactions ISO RGD:1350492 6480464 Valsartan inhibits the reaction [AGT protein results in increased expression of CYBB mRNA], Valsartan inhibits the reaction [AGT protein results in increased expression of CYBB protein] CTD PMID:15643130 vanadyl sulfate decreases expression ISO RGD:1350492 6480464 vanadyl sulfate results in decreased expression of CYBB mRNA CTD PMID:16330358 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CYBB mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYBB mRNA CTD PMID:23034163 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of CYBB CTD PMID:20128680 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of CYBB CTD PMID:20128680
